Social and emotional adjustment in young survivors of childhood cancer

2001 ◽  
Vol 9 (7) ◽  
pp. 489-513 ◽  
Author(s):  
H. Stam ◽  
M. Grootenhuis ◽  
B. Last
2019 ◽  
Vol 38 (2) ◽  
pp. 842-847 ◽  
Author(s):  
Alexia J. Murphy-Alford ◽  
Melinda White ◽  
Liane Lockwood ◽  
Andrew Hallahan ◽  
Peter S.W. Davies

2020 ◽  
Vol 67 (9) ◽  
Author(s):  
Lauren M. Touyz ◽  
Jennifer Cohen ◽  
Sarah P. Garnett ◽  
Allison M. Grech ◽  
Paayal Gohil ◽  
...  

2008 ◽  
pp. 163-188 ◽  
Author(s):  
Angela de Boer ◽  
Jos Verbeek ◽  
Frank van Dijk

2021 ◽  
Author(s):  
Catharine A.K. Fleming ◽  
Alexia J. Murphy‐Alford ◽  
Jennifer Cohen ◽  
Michael R. Fleming ◽  
Claire E. Wakefield ◽  
...  

2015 ◽  
Vol 24 (9) ◽  
pp. 2151-2161 ◽  
Author(s):  
L. Wengenroth ◽  
M. E. Gianinazzi ◽  
C. S. Rueegg ◽  
S. Lüer ◽  
E. Bergstraesser ◽  
...  

2019 ◽  
pp. bmjspcare-2019-002001
Author(s):  
Christina Signorelli ◽  
Claire Wakefield ◽  
Jordana K McLoone ◽  
Joanna Fardell ◽  
Janelle M Jones ◽  
...  

ObjectiveMany survivors are disengaged from follow-up, mandating alternative models of survivorship-focused care for late effects surveillance. We explored survivors’ barriers to accessing, and preferences for survivorship care.MethodsWe invited Australian and New Zealand survivors of childhood cancer from three age groups: <16 years (represented by parents), 16–25 years (adolescent and young adults (AYAs)) and >25 years (‘older survivors’). Participants completed questionnaires and optional interviews.Results633 survivors/parents completed questionnaires: 187 parents of young survivors (mean age: 12.4 years), 251 AYAs (mean age: 20.6 years) and 195 older survivors (mean age: 32.5 years). Quantitative data were complemented by 151 in-depth interviews. Most participants, across all age groups, preferred specialised follow-up (ie, involving oncologists, nurses or a multidisciplinary team; 86%–97%). Many (36%–58%) were unwilling to receive community-based follow-up. More parents (75%) than AYAs (58%) and older survivors (30%) were engaged in specialised follow-up. While follow-up engagement was significantly lower in older survivors, survivors’ prevalence of late effects increased. Of those attending a follow-up clinic, 34%–56% were satisfied with their care, compared with 14%–15% of those not receiving cancer-focused care (p<0.001). Commonly reported barriers included lack of awareness about follow-up availability (67%), followed by logistical (65%), care-related beliefs (59%) and financial reasons (57%). Older survivors (p<0.001), living outside major cities (p=0.008), and who were further from diagnosis (p=0.014) reported a higher number of barriers.ConclusionsUnderstanding patient-reported barriers, and tailoring care to survivors’ follow-up preferences, may improve engagement with care and ensure that the survivorship needs of this population are met.


2015 ◽  
Vol 4 (2) ◽  
pp. 86-98
Author(s):  
Elisa Kern de Castro ◽  
Renata Klein Zancan ◽  
Lauro José Gregianin

ObjetivoEste estudo teve como objetivo avaliar a presença de Transtorno de Estresse Pós-Traumático (TEPT) e a sua relação com a perceção da doença numa amostra de 65 jovens sobreviventes de cancro infantil, com uma média de idades de 19 anos (DP= 2,70) e que tinham terminado o tratamento, em média, há sete anos.MétodoForam aplicados instrumentos para obtenção de dados sociodemográficos e clínicos, de sintomas de TEPT – “Posttraumatic Stress Disorder Checklist – Civilian” (PCL-C) e de perceção da doença – “Revised Illness Perception Questionnaire for Healthy People” (IPQ-RH).ResultadosA presença de sintomas de TEPT variade 9,2% a 18,5% na amostra, e a perceção da doença esteve correlacionada com os sintomas deste transtorno. As subescalas Representação Emocional e Coerência da Doença (IPQ-RH), foram preditoras dos sintomas de Reexperiência (β = 0,0370; p < 0,01; β = 0,261; p<0,05, respetivamente). A subescala Representação Emocional (IPQ-RH) também foi preditora de sintomas de Esquiva (β = 0,330; p < 0,001).ConclusãoConcluiu-se que a perceção da doença deve ser investigada para prevenir os sintomas de TEPT em sobreviventes de câncer infantil.


Sign in / Sign up

Export Citation Format

Share Document